Crossover Study of Zafirlukast in Preventing Allergen-induced Signs and Symptoms in Response to Cat Dander Challenge
Clinical trial NCT06069063 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06069063
- Sponsor
- Allergy & Asthma Medical Group & Research Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-05
- Primary completion
- 2026-06-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.